• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 3 Device Recall Smith & Nephew, Well Leg Holder

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 3 Device Recall Smith & Nephew, Well Leg Holder see related information
Date Initiated by Firm November 01, 2006
Date Posted June 06, 2007
Recall Status1 Terminated 3 on June 16, 2008
Recall Number Z-0872-2007
Recall Event ID 37792
Product Classification Well Leg Holder (Arthroscopic Accessory) - Product Code NBH
Product Well Leg Holder With Boot, part of the Supine Universal Hip Distractor System; Ref (Part) #72200632; Manufactured for Smith & Nephew, Inc., Endoscopy Divsion, Andover, MA 01810.
Code Information Serial #s: 286092, 287285, 287287, 287288, 287289, 287290, 287291, 289740, 289743, 290456, 290457 and 290837.
Recalling Firm/
Manufacturer
Smith & Nephew, Inc Endoscopy Division
76 S. Meridian Ave
Oklahoma City OK 73107-6512
Manufacturer Reason
for Recall
The device was not manufactured to correct specification causing interference when used in conjunction with Patient Transfer Board.
FDA Determined
Cause 2
Other
Action Firm notified consignees by letter and phone call on 11/1/2006. Consignees asked to return out-of-spec Well Leg Holder for a replacement.
Quantity in Commerce 12
Distribution Nationwide Distribution: USA including states of WI, CA, MO, IL, TX, MA, WA, NM, FL, NH, and SC and the UK
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-